Zheng Sun
Tracked across 1 events · 6 articles · First seen Jun 05, 2026 · Last active Jun 24, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Dr. Zheng Sun is the corresponding author of the study, leading the research that challenges the traditional understanding of HDAC inhibitors and proposing new avenues for cancer treatment.
Jun 05, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Zheng Sun live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard